{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:25Z","timestamp":1777984285798,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04189-3","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:27:42Z","timestamp":1770373662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydroethanolic root extract of Croton membranaceus suppresses angiogenesis in zinc\u2013testosterone-induced prostate adenocarcinoma and chorioallantoic membrane models"],"prefix":"10.1186","volume":"26","author":[{"given":"Kofi Oduro","family":"Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mavis Sersah","family":"Nyarko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron Opoku","family":"Antwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Nimoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard Elikplim","family":"Petershie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Ashie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boakye-Gyasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newman","family":"Osafo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Amankwah","family":"Ntim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ainooson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"3","key":"4189_CR1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212539","volume":"219","author":"P Li","year":"2022","unstructured":"Li P, Ferrara N. Vascular heterogeneity: VEGF receptors make blood vessels special. J Exp Med. 2022;219(3):e20212539. https:\/\/doi.org\/10.1084\/jem.20212539.","journal-title":"J Exp Med"},{"key":"4189_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174021","volume":"899","author":"D Parmar","year":"2021","unstructured":"Parmar D, Apte M. Angiopoietin inhibitors: a review on targeting tumor angiogenesis. Eur J Pharmacol. 2021;899:174021.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"4189_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/life13102034","volume":"13","author":"F Grizzi","year":"2023","unstructured":"Grizzi F, Hegazi MAAA, Zanoni M, Vota P, Toia G, Clementi MC, et al. Prostate cancer microvascular routes: exploration and measurement strategies. Life. 2023;13(10):2034. https:\/\/doi.org\/10.3390\/life13102034.","journal-title":"Life"},{"key":"4189_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"issue":"1","key":"4189_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4189_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jare.2017.06.006","volume":"8","author":"AM Al-Abd","year":"2017","unstructured":"Al-Abd AM, Alamoudi AJ, Abdel-Naim AB, Neamatallah TA, Ashour OM. Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies - A review. J Adv Res. 2017;8(6):591\u2013605. https:\/\/doi.org\/10.1016\/j.jare.2017.06.006.","journal-title":"J Adv Res"},{"issue":"4","key":"4189_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9040032","volume":"9","author":"K Eisermann","year":"2017","unstructured":"Eisermann K, Fraizer G. The androgen receptor and VEGF: mechanisms of androgen-regulated angiogenesis in prostate cancer. Cancers. 2017;9(4):32. https:\/\/doi.org\/10.3390\/cancers9040032.","journal-title":"Cancers"},{"issue":"10","key":"4189_CR8","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/ijc.31237","volume":"142","author":"Y Luo","year":"2018","unstructured":"Luo Y, Azad AK, Karanika S, Basourakos SP, Zuo X, Wang J, Yang L, Yang G, Korentzelos D, Yin J, Park S, Zhang P, Campbell JJ, Schall TJ, Cao G, Li L, Thompson TC. Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models. Int J Cancer. 2018;142(10):2163\u201374. https:\/\/doi.org\/10.1002\/ijc.31237.","journal-title":"Int J Cancer"},{"issue":"6","key":"4189_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1124\/mol.114.097477","volume":"87","author":"EV Fernandez","year":"2015","unstructured":"Fernandez EV, Reece KM, Ley AM, Troutman SM, Sissung TM, Price DK, Chau CH, Figg WD. Dual targeting of the androgen receptor and hypoxia-inducible factor 1\u03b1 pathways synergistically inhibits castration-resistant prostate cancer cells. Mol Pharmacol. 2015;87(6):1006\u201312. https:\/\/doi.org\/10.1124\/mol.114.097477.","journal-title":"Mol Pharmacol"},{"key":"4189_CR10","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/annonc\/mdx361.028","volume":"28","author":"PJ Maxwell","year":"2017","unstructured":"Maxwell PJ, Labonte M, McKechnie M, Duddy O, Armstrong C, Ong CW, Waugh D. Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer. Ann Oncol. 2017;28:v8\u20139.","journal-title":"Ann Oncol"},{"key":"4189_CR11","unstructured":"Schmelzer GH. (2007). Croton membranaceus M\u00fcll.Arg. In: Schmelzer, G.H. & Gurib-Fakim, A, editors. PROTA (Plant Resources of Tropical Africa \/ Ressources v\u00e9g\u00e9tales de l\u2019Afrique tropicale), Wageningen, Netherlands. Available: https:\/\/uses.plantnet-project.org\/en\/Croton_membranaceus_(PROTA). [Accessed 30\/04\/2024]."},{"issue":"1","key":"4189_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5455\/jcmr.20180718123349","volume":"9","author":"A Maroyi","year":"2018","unstructured":"Maroyi A. Review of Croton Membranaceus M\u00fbll. Arg.: phytochemical, pharmacological and toxicological perspective. J Complement Med Res. 2018;9(1):24\u201333. https:\/\/doi.org\/10.5455\/jcmr.20180718123349.","journal-title":"J Complement Med Res"},{"issue":"3","key":"4189_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4314\/gmj.v51i3.6","volume":"51","author":"MY Kyei","year":"2017","unstructured":"Kyei MY, Klufio GO, Ayamba A, Mohammed S. Traditional medicines and alternative practice in the management of prostate diseases in Southern Ghana. Ghana Med J. 2017;51(3):128\u201337. https:\/\/doi.org\/10.4314\/gmj.v51i3.6.","journal-title":"Ghana Med J"},{"key":"4189_CR14","doi-asserted-by":"publisher","DOI":"10.23893\/1307-2080.aps6109","author":"KO Yeboah","year":"2023","unstructured":"Yeboah KO, Emosivbe M, Ntim EA, Sam GH, Ainooson G. The antiproliferative, antimigratory and anticlonogenic effects of Croton membranaceus M? ll. Arg.(Euphorbiaceae) hydroethanolic root extract in human 22Rv1 castration-resistant prostate cancer cells. Acta Pharm Sci. 2023. https:\/\/doi.org\/10.23893\/1307-2080.aps6109.","journal-title":"Acta Pharm Sci"},{"key":"4189_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/365205","volume":"2015","author":"GA Asare","year":"2015","unstructured":"Asare GA, Afriyie D, Ngala RA, Appiah AA, Anang Y, Musah I, et al. Shrinkage of prostate and improved quality of life: management of BPH patients with Croton membranaceus ethanolic root extract. Evid Based Complement Alternat Med. 2015;2015:365205. https:\/\/doi.org\/10.1155\/2015\/365205.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"11","key":"4189_CR16","doi-asserted-by":"publisher","first-page":"e27385","DOI":"10.1371\/journal.pone.0027385","volume":"6","author":"E Zudaire","year":"2011","unstructured":"Zudaire E, Gambardella L, Kurcz C, Vermeren S. A computational tool for quantitative analysis of vascular networks. PLoS One. 2011;6(11):e27385.","journal-title":"PLoS One"},{"issue":"4","key":"4189_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd7040056","volume":"7","author":"W Burggren","year":"2020","unstructured":"Burggren W, Rojas Antich M. Angiogenesis in the avian embryo chorioallantoic membrane: a perspective on research trends and a case study on toxicant vascular effects. J Cardiovasc Dev Dis. 2020;7(4):56. https:\/\/doi.org\/10.3390\/jcdd7040056.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"4189_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14893-4","volume":"25","author":"KO Yeboah","year":"2025","unstructured":"Yeboah KO, Atawuchugi P, Baah FK, Petershie BE, Ashie Y, Boakye-Gyasi E, et al. The impact of zinc and testosterone co-treatment on tumourigenesis in prostate cancer: a novel model. BMC Cancer. 2025;25(1):1552. https:\/\/doi.org\/10.1186\/s12885-025-14893-4.","journal-title":"BMC Cancer"},{"key":"4189_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/919570","volume":"2014","author":"C Benazzi","year":"2014","unstructured":"Benazzi C, Al-Dissi A, Chau CH, Figg WD, Sarli G, de Oliveira JT, et al. Angiogenesis in spontaneous tumors and implications for comparative tumor biology. Sci World J. 2014;2014:919570. https:\/\/doi.org\/10.1155\/2014\/919570.","journal-title":"Sci World J"},{"key":"4189_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0084-4","volume":"35","author":"Y Cao","year":"2016","unstructured":"Cao Y. Future options of anti-angiogenic cancer therapy. Chin J Cancer. 2016;35:21. https:\/\/doi.org\/10.1186\/s40880-016-0084-4.","journal-title":"Chin J Cancer"},{"issue":"1","key":"4189_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10585-021-10120-z","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis. 2022;39(1):159\u201379. https:\/\/doi.org\/10.1007\/s10585-021-10120-z.","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"4189_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112676","volume":"20","author":"Z Melegh","year":"2019","unstructured":"Melegh Z, Oltean S. Targeting angiogenesis in prostate cancer. Int J Mol Sci. 2019;20(11):2676. https:\/\/doi.org\/10.3390\/ijms20112676.","journal-title":"Int J Mol Sci"},{"issue":"694","key":"4189_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade5855","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang M, Wisniewski CA, Xiong C, Chhoy P, Goel HL, Kumar A, et al. Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Sci Transl Med. 2023;15(694):eade5855. https:\/\/doi.org\/10.1126\/scitranslmed.ade5855.","journal-title":"Sci Transl Med"},{"issue":"2","key":"4189_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1538\/expanim.14-0059","volume":"64","author":"CS Kue","year":"2015","unstructured":"Kue CS, Tan KY, Lam ML, Lee HB. Chick embryo Chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp Anim. 2015;64(2):129\u201338. https:\/\/doi.org\/10.1538\/expanim.14-0059.","journal-title":"Exp Anim"},{"key":"4189_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-99609-2_13","volume-title":"Handbook of Microcirculation. Physiology in health and disease","author":"D Fukumura","year":"2025","unstructured":"Fukumura D. Tumor microcirculation: abnormalities and normalization. In: Tuma RF, Breslin JW, Peirce-Cottler S, Murfee WL, editors. Handbook of Microcirculation. Physiology in health and disease. Cham: Springer; 2025. https:\/\/doi.org\/10.1007\/978-3-031-99609-2_13."},{"key":"4189_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep43378","volume":"7","author":"Y Nordby","year":"2017","unstructured":"Nordby Y, Richardsen E, Rakaee M, Ness N, Donnem T, Patel HR, et al. High expression of PDGFR-\u03b2 in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Sci Rep. 2017;7:43378. https:\/\/doi.org\/10.1038\/srep43378.","journal-title":"Sci Rep"},{"key":"4189_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00020","volume":"7","author":"G Manzo","year":"2019","unstructured":"Manzo G. Similarities between embryo development and cancer process suggest new strategies for research and therapy of tumors: a new point of view. Front Cell Dev Biol. 2019;7:20. https:\/\/doi.org\/10.3389\/fcell.2019.00020.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4189_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/ijms23010452","volume":"23","author":"DC Kennedy","year":"2021","unstructured":"Kennedy DC, Coen B, Wheatley AM, McCullagh KJA. Microvascular experimentation in the chick chorioallantoic membrane as a model for screening angiogenic agents including from gene-modified cells. Int J Mol Sci. 2021;23(1):452. https:\/\/doi.org\/10.3390\/ijms23010452.","journal-title":"Int J Mol Sci"},{"key":"4189_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26:313\u201347.","journal-title":"Angiogenesis"},{"issue":"2","key":"4189_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1549-8719.2010.00075.x","volume":"18","author":"DJ Gould","year":"2011","unstructured":"Gould DJ, Vadakkan TJ, Poch\u00e9 RA, Dickinson ME. Multifractal and lacunarity analysis of microvascular morphology and remodeling. Microcirculation. 2011;18(2):136\u201351. https:\/\/doi.org\/10.1111\/j.1549-8719.2010.00075.x.","journal-title":"Microcirculation"},{"key":"4189_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2025.106972","volume":"4","author":"AZM Barizi","year":"2025","unstructured":"Barizi AZM, Abdullah MNH, Lim V, Yong YK. Astaxanthin\u2019s anti-angiogenic effects: network pharmacology and functional validation in endothelial cells. Food Biosci. 2025;4:106972. https:\/\/doi.org\/10.1016\/j.fbio.2025.106972.","journal-title":"Food Biosci"},{"issue":"4","key":"4189_CR32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0002-9440(10)63905-3","volume":"162","author":"P Guo","year":"2003","unstructured":"Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol. 2003;162(4):1083\u201393. https:\/\/doi.org\/10.1016\/S0002-9440(10)63905-3.","journal-title":"Am J Pathol"},{"issue":"3","key":"4189_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph3030572","volume":"3","author":"M Raica","year":"2010","unstructured":"Raica M, Cimpean AM. Platelet-Derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals (Basel Switzerland). 2010;3(3):572\u201399. https:\/\/doi.org\/10.3390\/ph3030572.","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"issue":"52","key":"4189_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2411640121","volume":"121","author":"M Hata","year":"2024","unstructured":"Hata M, Hata M, Dejda A, Pilon F, Diaz-Marin R, Fournier F, et al. Corticosteroids reduce pathological angiogenesis yet compromise reparative vascular remodeling in a model of retinopathy. Proc Natl Acad Sci U S A. 2024;121(52):e2411640121. https:\/\/doi.org\/10.1073\/pnas.2411640121.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04189-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04189-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:10:37Z","timestamp":1773061837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04189-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04189-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7782041\/v1","asserted-by":"object"}]},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The department review board on the use of animals for experimental purposes, the Department of Pharmacology Animal Research Ethics Committee (DPAREC) of KNUST, Ghana approved (Approval No: PCOL\/23\/016) all the protocols used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}